Saturday, July 2, 2011

Asodocel




Asodocel may be available in the countries listed below.


Ingredient matches for Asodocel



Docetaxel

Docetaxel is reported as an ingredient of Asodocel in the following countries:


  • Argentina

Docetaxel trihydrate (a derivative of Docetaxel) is reported as an ingredient of Asodocel in the following countries:


  • Argentina

International Drug Name Search

Tuesday, June 28, 2011

Ferro sanol gyn




Ferro sanol gyn may be available in the countries listed below.


Ingredient matches for Ferro sanol gyn



Ferrous Glycine Sulfate

Ferrous Glycine Sulfate is reported as an ingredient of Ferro sanol gyn in the following countries:


  • Germany

Folic Acid

Folic Acid is reported as an ingredient of Ferro sanol gyn in the following countries:


  • Germany

International Drug Name Search

Céfotaxime Mylan




Céfotaxime Mylan may be available in the countries listed below.


Ingredient matches for Céfotaxime Mylan



Cefotaxime

Cefotaxime sodium salt (a derivative of Cefotaxime) is reported as an ingredient of Céfotaxime Mylan in the following countries:


  • France

International Drug Name Search

Monday, June 27, 2011

Prograf


Prograf is a brand name of tacrolimus, approved by the FDA in the following formulation(s):


PROGRAF (tacrolimus - capsule; oral)



  • Manufacturer: ASTELLAS

    Approval date: April 8, 1994

    Strength(s): EQ 1MG BASE [AB], EQ 5MG BASE [RLD][AB]


  • Manufacturer: ASTELLAS

    Approval date: August 24, 1998

    Strength(s): EQ 0.5MG BASE [AB]

PROGRAF (tacrolimus - injectable; injection)



  • Manufacturer: ASTELLAS

    Approval date: April 8, 1994

    Strength(s): EQ 5MG BASE/ML [RLD]

Has a generic version of Prograf been approved?


A generic version of Prograf has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Prograf and have been approved by the FDA:


tacrolimus capsule; oral



  • Manufacturer: DR REDDYS LABS LTD

    Approval date: May 12, 2010

    Strength(s): EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 5MG BASE [AB]


  • Manufacturer: MYLAN

    Approval date: September 17, 2010

    Strength(s): EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 5MG BASE [AB]


  • Manufacturer: SANDOZ

    Approval date: August 10, 2009

    Strength(s): EQ 0.5MG BASE [AB], EQ 1MG BASE [AB], EQ 5MG BASE [AB]


  • Manufacturer: WATSON LABS

    Approval date: July 1, 2010

    Strength(s): EQ 5MG BASE [AB]

Note: No generic formulation of the following product is available.


  • tacrolimus - injectable; injection

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Prograf. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Prograf.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • March 29, 2013 - ORPHAN DRUG EXCLUSIVITY

See also...

  • Prograf Consumer Information (Drugs.com)
  • Prograf Consumer Information (Wolters Kluwer)
  • Prograf Capsules Consumer Information (Wolters Kluwer)
  • Prograf Consumer Information (Cerner Multum)
  • Prograf Advanced Consumer Information (Micromedex)
  • Prograf AHFS DI Monographs (ASHP)
  • Tacrolimus Consumer Information (Wolters Kluwer)
  • Tacrolimus Capsules Consumer Information (Wolters Kluwer)
  • Tacrolimus Consumer Information (Cerner Multum)
  • Tacrolimus Oral, Intravenous Advanced Consumer Information (Micromedex)
  • Tacrolimus AHFS DI Monographs (ASHP)

Sunday, June 26, 2011

Abelcet




In the US, Abelcet (amphotericin b lipid complex systemic) is a member of the drug class polyenes and is used to treat Aspergillosis - Aspergilloma, Aspergillosis - Invasive, Blastomycosis, Candida Infections - Systemic, Coccidioidomycosis, Cryptococcosis, Histoplasmosis and Leishmaniasis.

US matches:

  • Abelcet

UK matches:

  • Abelcet
  • Abelcet (Cephalon (UK) Limited) (SPC)

Ingredient matches for Abelcet



Amphotericin B

Amphotericin B is reported as an ingredient of Abelcet in the following countries:


  • Belgium

  • Poland

  • Sweden

Amphotericin B phospholipid complex (a derivative of Amphotericin B) is reported as an ingredient of Abelcet in the following countries:


  • Argentina

  • Australia

  • Austria

  • Czech Republic

  • Denmark

  • Finland

  • France

  • Germany

  • Greece

  • Hungary

  • Iceland

  • Ireland

  • Italy

  • Luxembourg

  • Netherlands

  • Norway

  • Oman

  • Singapore

  • Slovakia

  • Spain

  • Turkey

  • United Kingdom

  • United States

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, June 23, 2011

Stalene




Stalene may be available in the countries listed below.


Ingredient matches for Stalene



Fluconazole

Fluconazole is reported as an ingredient of Stalene in the following countries:


  • Singapore

International Drug Name Search

Sunday, June 19, 2011

Pratol




Pratol may be available in the countries listed below.


Ingredient matches for Pratol



Felodipine

Felodipine is reported as an ingredient of Pratol in the following countries:


  • Romania

International Drug Name Search